Ev
Evommune
Burlingame CAFounded 202115 employees
Private CapbiotechPrivateDermatology
Platform: EVO101 PNP
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
3
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimanaritide | EVO-3568 | Phase 1 | 1 | PCSK9 | PTSD | ||
| EVO-481 | EVO-481 | Preclinical | 1 | JAK1 | Schizophrenia | ||
| EVO-4804 | EVO-4804 | Approved | 2 | IL-17A | NB | ||
| EVO-1057 | EVO-1057 | Phase 3 | 3 | TYK2 | Huntington'sT2D |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)